WASHINGTON (dpa-AFX) – Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY): Earnings: $147.75 million in Q3 vs. -$405.92 million in the same period last year. EPS: $1.15 in Q3 vs. -$3.32 in the same period last year. Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of $228.53 million…Read More
Alnylam Pharmaceuticals Inc Q3 Earnings Summary
